-
Perinatal Outcomes in Siblings from Different Conception Methods: In Vitro Fertilization with Autologous Oocyte or Donor Egg vs. Unassisted Medical Conception. Fertil. Steril. (IF 6.6) Pub Date : 2024-12-13 Hila Shalev-Ram,Anat Hershko Klement,Einat Haikin-Herzberger,Mattan Levi,Roni Rahav-Koren,Amir Wiser,Netanella Miller
OBJECTIVE To study the perinatal outcomes of children born from different conception methods: in vitro fertilization (IVF) with autologous oocytes or IVF with donor egg versus those conceived without medical assistance by using a sibling analysis. DESIGN Retrospective cohort study conducted using electronic medical record data from 2000 through 2018, of a national healthcare organization. SUBJECTS
-
Comment on: Similar accuracy and patient experience with different one-step ovulation predictor kits. Fertil. Steril. (IF 6.6) Pub Date : 2024-12-13 Sarah C Cromack,Jessica R Walter
-
The Benefit Of Ovary Cortex Allotransplantation Using Immunosuppression. Fertil. Steril. (IF 6.6) Pub Date : 2024-12-12 Sherman J Silber,Sierra Goldsmith,Benjamin Rubinoff,Eduardo Kelly,Rowena Delos Santos,Anibal Melo,Daniel Brennan
-
Using National IVF Registries to Validate Clinical Outcomes Following IVF Covered by Health Insurance. Fertil. Steril. (IF 6.6) Pub Date : 2024-12-12 David Suh,Phyllis Yan,Rodney L Dunn,Edward C Norton,Vanessa K Dalton,Erica E Marsh,Marissa S Weiss,James M Dupree
OBJECTIVE To evaluate in vitro fertilization (IVF) cycles covered by health insurance using a national commercial claims database and to validate key clinical events against national IVF registries. DESIGN Retrospective cohort study SUBJECTS: US women aged 20-44 who underwent IVF from 2005 to 2020 in Optum's de-identified Clinformatics® Data Mart Database (CDM). EXPOSURE Undergoing IVF MAIN OUTCOME
-
Sexual response in women with Polycystic Ovary Syndrome: a case control study. Fertil. Steril. (IF 6.6) Pub Date : 2024-12-11 Hester Pastoor,Ellen Laan,Joop Laven,Stephanie Both
OBJECTIVE To study genital response and sexual arousal in women with and without PCOS and to assess associations with sex steroid levels. DESIGN This observational prospective case control study was conducted from March 2017 until March 2020. SUBJECTS Heterosexual women with (n=68) and without PCOS (n=67), aged 18-40 years, in a steady relationship and without any comorbidities. EXPOSURE All participants
-
A blastocyst's implantation potential is linked to its originating oocyte cohort's blastulation rate: evidence for a cohort effect. Fertil. Steril. (IF 6.6) Pub Date : 2024-12-11 David Huang,Justina Hyunjii Cho,Michael Fanton,Eleni Jaswa,Marcelle I Cedars,Mitchell P Rosen
OBJECTIVE To investigate if blastocysts originating from different follicular cohorts have variable implantation rates, adjusted for oocyte age, morphology and/or ploidy DESIGN: Retrospective cohort SETTING: Academic center SUBJECTS: Patients who underwent one or more cycles of autologous ovarian stimulation and in vitro fertilization/intracytoplasmic sperm injection, followed by elective single frozen
-
A re-look at the relevance of TSH and thyroid autoimmunity for pregnancy outcomes: Analyses of RCT data from PPCOS II and AMIGOS. Fertil. Steril. (IF 6.6) Pub Date : 2024-12-11 Satu Kuokkanen,Aimee Seungdamrong,Nanette Santoro,Harry Lieman,Fangbai Sun,Robert Wild,Heping Zhang,Lubna Pal
OBJECTIVE We examined if thyroid autoimmunity is relevant to the relationship between maternal TSH levels and pregnancy outcomes. DESIGN Retrospective cohort analysis of data from two randomized controlled trials (RCTs). SUBJECTS Participants of the Pregnancy in Polycystic Ovary Syndrome (PPCOS II, n = 746) and the Assessment of Multiple Intrauterine Gestations from Ovarian Stimulation (AMIGOS, n =
-
Perinatal and infant outcomes following ART treatment for endometriosis alone compared with other causes of infertility: a data linkage cohort study. Fertil. Steril. (IF 6.6) Pub Date : 2024-12-11 Xian Zhang,Georgina M Chambers,Christos Venetis,Stephanie K Y Choi,Brigitte Gerstl,Cecilia H M Ng,Jason A Abbott
OBJECTIVE To evaluate whether perinatal and infant outcomes differ between singleton births following assisted reproductive technology (ART) in women with endometriosis alone and those with other causes of infertility. DESIGN Population-based data linkage cohort study. SUBJECTS A total of 29,152 ART-conceived singleton births from 24,116 mothers, 2010-2017, New South Wales, Australia. EXPOSURE Endometriosis
-
Systematic review and Meta-analysis of the impact of the re-freezing and re- biopsy embryos on reproductive outcomes in patients undergoing freeze-thaw embryo transfer. Fertil. Steril. (IF 6.6) Pub Date : 2024-12-11 Yuan Yang,Dan Li,Yongmei Liu,Yuxin Qi,Hongrui Li,Zhe Wang,Bin Ma
IMPORTANCE During FET cycles in IVF/ICSI patients (including PGT patients), transfer of embryos that have been thawed may be abandoned for medical or personal reasons, resulting in the need to refreeze embryos. Typically, embryos from patients undergoing preimplantation genetic testing (PGT) are cryopreserved after biopsy, pending test results. However, in the absence of a clear result, another biopsy
-
Effects of preimplantation genetic testing for aneuploidy on embryo transfer outcomes in women of advanced reproductive age with no more than three retrieved oocytes. Fertil. Steril. (IF 6.6) Pub Date : 2024-12-11 Zhanhui Ou,Nengqing Liu,Ang Chen,Qingni Li,Jieliang Li,Xiaojun Wen,Junye Huo,Xiaowu Fang,Jing Du,Xiufeng Lin
OBJECTIVE To evaluate whether preimplantation genetic testing for aneuploidy (PGT-A) benefits women of advanced reproductive age (≥38 years old) with a diminished ovarian reserve (DOR; not more than three retrieved oocytes). DESIGN A retrospective analysis comparing two groups: (a) PGT-A group: women who chose PGT-A and subsequent single re-warmed embryo transfers (ETs) and (b) non-PGT-A group: women
-
Mood lability and depression limit oral contraceptive therapy in endometriosis. Fertil. Steril. (IF 6.6) Pub Date : 2024-12-11 Esma Cansu Cevik,Hugh S Taylor
OBJECTIVE To determine the impact of oral contraceptive (OC) induced mood lability/depression on treatment maintenance in women with endometriosis. DESIGN Women with endometriosis were retrospectively identified through International Classification of Diseases-10 codes and then a comprehensive electronic medical record review was conducted, identifying mood lability/depression as a reason for treatment
-
Should physicians be facilitating gestational carrier arrangements in the absence of medical indication? Fertil. Steril. (IF 6.6) Pub Date : 2024-12-11 Brian Levine M.D. M.S., Alexis L. Cirel Esq., Kate D. Schoyer M.D., Arthur R. Derse M.D. J.D., Robert T. Rydze M.D., Eve C. Feinberg M.D.
-
To Be Frank: Is it Time to Say Goodbye to Abbe-McIndoe and Vecchietti? Fertil. Steril. (IF 6.6) Pub Date : 2024-12-10 Marisa Imbroane,Allison Bosch,Elliott G Richards
-
Impact of corpus luteum number on maternal pregnancy and birth outcomes: the Rotterdam Periconception Cohort. Fertil. Steril. (IF 6.6) Pub Date : 2024-12-05 Joni J Koerts,Lotte W Voskamp,Melek Rousian,Régine P M Steegers-Theunissen,Rosalieke E Wiegel
OBJECTIVE To investigate associations between assisted reproductive technology (ART) -induced alterations in corpus luteum (CL) number during implantation, and maternal pregnancy and birth outcomes. Pregnancies conceived through ART are associated with increased risks of adverse obstetric and perinatal outcomes, with discrepancies in outcomes between different ART treatment protocols. We hypothesize
-
Criteria for the fellowship match: Are we using the right parameters? Fertil. Steril. (IF 6.6) Pub Date : 2024-12-04 Ruben Alvero,Ruth B Lathi
-
Highlighting the importance of identity formation and the implications for psychological well- being among donor conceived individuals. Fertil. Steril. (IF 6.6) Pub Date : 2024-12-03 Mary P Riddle
-
Polycystic ovarian morphology (PCOM): the number of chocolate chips is more important than the size of the cookie. Fertil. Steril. (IF 6.6) Pub Date : 2024-12-03 Alexander M Quaas
-
Pulsatile gonadotropin-releasing hormone therapy: does one size fit all? Fertil. Steril. (IF 6.6) Pub Date : 2024-12-03 Luce A. Kassi M.D., Jennifer L. Eaton M.D. M.S.C.I.
-
-
-
-
Tips and Tricks for Robotic Management of Diffuse Adenomyosis. Fertil. Steril. (IF 6.6) Pub Date : 2024-11-29 Gaby Moawad,Anis Feki,Jean Marc Ayoubi,Antoine Naem,Youssef Youssef
-
Embryoscopy with hysteroscopy for a more full-scope assessment and management of early miscarriage. Fertil. Steril. (IF 6.6) Pub Date : 2024-11-28 Salomeh Salari,Steven R Lindheim
-
Anti-Mullerian Hormone and Antral Follicle Count Thresholds for Hyper-Response Risk Assessment in IVF: A HERA Consensus Study. Fertil. Steril. (IF 6.6) Pub Date : 2024-11-25 Alyssa Hochberg,Sandro C Esteves,Hakan Yarali,Lan N Vuong,Michael H Dahan
OBJECTIVE To determine the serum anti-Müllerian-hormone (AMH) and antral follicle count (AFC) thresholds indicating an increased risk of hyper-response to ovarian stimulation (OS) during in-vitro-fertilization (IVF), as defined by the HERA (Hyper-response Risk Assessment) Delphi Consensus. DESIGN A retrospective multicenter cohort study. SUBJECTS Included were women with normal ovarian reserve markers
-
Reproductive outcome after fertility treatment in women with von Willebrand disease: a retrospective cohort study Fertil. Steril. (IF 6.6) Pub Date : 2024-11-22 Lennert Haack M.D., Bjarne Dasenbrook M.Sc., Paula Steiner M.D., Beate Krammer-Steiner M.D., Michael Steiner M.D., Johannes Stubert M.D.
Capsule: The most frequent inherited bleeding disorder, von Willebrand disease, does not negatively affect reproductive outcomes in women undergoing fertility treatment as clinical pregnancy rates, pregnancy loss rates, and baby take-home rates were all similar to the control group.
-
Value of ultrasound-based endometriosis staging system in anticipating complexity of laparoscopic surgery Fertil. Steril. (IF 6.6) Pub Date : 2024-11-20 Mahbod Ebrahimi M.D. Ph.D., Sholeh Naghdi M.D., Fatemeh Davari-Tanha M.D. Ph.D., Behnaz Moradi M.D. Ph.D., Elham Feizabad M.D., Kiana Majidi M.D.
To evaluate the effectiveness of the preoperative ultrasound-based endometriosis staging system (UBESS) in anticipating the complexity of laparoscopic surgery for optimal patient counseling and treatment.
-
Impact of prednisone on vasectomy reversal outcomes (iPRED study): results from a randomized, controlled clinical trial Fertil. Steril. (IF 6.6) Pub Date : 2024-11-20 Landon Trost M.D., Sevann Helo M.D., Klinton Brearton D.N.P.-C., Riley Warner P.A.-C., Matthew Ziegelmann M.D., Tobias Kohler M.D., Joshua Savage P.A.-C.
To evaluate the safety and efficacy of prednisone on pregnancy rates and semen concentrations at 1 year after vasectomy reversal.
-
-
Ovarian tissue allografts: the next frontier of reproductive transplantation? Fertil. Steril. (IF 6.6) Pub Date : 2024-11-16 Kathryn Coyne M.D., Isabelle Mason M.D., Rebecca Flyckt M.D.
-
A long road ahead: medical management for endometriosis-related pain. Just keep looking Fertil. Steril. (IF 6.6) Pub Date : 2024-11-15 Jose Carugno M.D., Amira Quevedo M.D., Nash S. Moawad M.D. M.S.
-
Comment on: Endometriosis and mental health disorders: identification and treatment as part of a multimodal approach Fertil. Steril. (IF 6.6) Pub Date : 2024-11-15 Maria I. Zervou Ph.D., George N. Goulielmos Ph.D.
-
Classification of Human Ovarian Follicle Morphology: Recommendations of the NICHD-Sponsored Ovarian Nomenclature Workshop. Fertil. Steril. (IF 6.6) Pub Date : 2024-11-14 Jacqueline C Yano Maher,Mary B Zelinski,Kutluk H Oktay,Francesca E Duncan,James H Segars,Marla E Lujan,Hong Lou,Bohyun Yun,Sarina N Hanfling,Lauren E Schwartz,Monica M Laronda,Lisa M Halvorson,Kathleen E O'Neill,Veronica Gomez-Lobo
OBJECTIVE To develop a consensus on histologic human ovarian follicle staging nomenclature, provide guidelines for follicle density calculation, and assess changes due to fixation to enhance communication among clinicians and ovarian biology researchers in order to gain a deeper understanding of human fertility. METHODS Beginning in March 2021, the Ovarian Nomenclature Workshop's Follicle Classification
-
Triggering oocyte maturation in in vitro fertilization treatment in healthy responders: a systematic review and network meta-analysis Fertil. Steril. (IF 6.6) Pub Date : 2024-11-14 Yusuf Beebeejaun M.B.B.S. M.H.D.L., Timothy Copeland Ph.D., James M.N. Duffy D.Phil., Ippokratis Sarris D.M.l., Marian Showell M.P.H., Rui Wang Ph.D., Sesh K. Sunkara M.D.
To compare efficacy and safety of human chorionic gonadotropin (hCG), gonadotropin-releasing hormone (GnRH) agonist, dual, and double triggers in predicted healthy responders undergoing ovarian stimulation and in vitro fertilization.
-
An umbrella review of meta-analyses regarding the incidence of female-specific malignancies after fertility treatment Fertil. Steril. (IF 6.6) Pub Date : 2024-11-14 Srdjan Saso Ph.D., Jen F. Barcroft M.R.C.O.G., Lorraine S. Kasaven M.R.C.O.G., Nicolas Galazis M.R.C.O.G., Bríd Ní Dhonnabháin M.Sc., Karen J. Grewal M.R.C.O.G., Timothy Bracewell-Milnes M.R.C.O.G., Benjamin P. Jones M.R.C.O.G., Natalie Getreu Ph.D., Maxine Chan M.R.C.O.G., Anita Mitra Ph.D., Maya Al-Memar Ph.D., Jara Ben-Nagi M.D., J. Richard Smith Ph.D., Joseph Yazbek M.D., Dirk Timmerman Ph.D.,
Understanding the potential risks associated with fertility treatments (FTs) can guide clinical decision and patient counseling.
-
Parental balanced translocation carriers do not have decreased usable blastulation rates or live birth rates compared with infertile controls Fertil. Steril. (IF 6.6) Pub Date : 2024-11-13 Kyle Nguyen Le M.D., Marcy Maguire M.D., Nicolás Garrido Puchalt M.Sc. Ph.D., Laura Lidon M.Sc., Alejandro Sánchez-Martínez M.Sc., Jason Franasiak M.D. H.C.L.D., Emily Osman M.D. T.S.
To determine whether translocation carriers have a reduced number of usable blastocysts compared with infertile controls.
-
Response to: Enhancing health management in patients with primary ovarian insufficiency: an in-depth exploration of multimorbidity associations Fertil. Steril. (IF 6.6) Pub Date : 2024-11-12 Abirami Kirubarajan M.D. M.Sc., Alison K. Shea M.D. Ph.D.
-
Why frozen embryo transfer results are lower with vaginal progesterone? Did we miss something? Fertil. Steril. (IF 6.6) Pub Date : 2024-11-09 Dominique de Ziegler M.D., Sean Soktean M.D., Paul Pirtea M.D.
-
Conceiving a new idea: fertile grounds for large-scale in vitro fertilization mergers Fertil. Steril. (IF 6.6) Pub Date : 2024-11-09 Amanda Ferraro M.D., M. Blake Evans D.O.
-
Luteinizing hormone’s critical role in ovarian stimulation Fertil. Steril. (IF 6.6) Pub Date : 2024-11-09 James P. Toner M.D. Ph.D, Paul Pirtea M.D.
-
Response to “A comparison of pregnancy outcomes and congenital malformations in offspring between patients undergoing intracytoplasmic sperm injection and conventional in vitro fertilization: a retrospective cohort study” Fertil. Steril. (IF 6.6) Pub Date : 2024-11-08 Katelyn Girtain Haywood B.S., Chelsea Fox M.D.
-
The ethics of egg sharing Fertil. Steril. (IF 6.6) Pub Date : 2024-11-08 Meera Shah M.D., Samuel Pang M.D., Lydia Hughes M.D., Katie Watson J.D., Eve C. Feinberg M.D., Eric A. Widra M.D.
-
-
Embryofetoscopy followed by hysteroscopic evacuation of a first trimester missed abortion in a woman with septate uterus Fertil. Steril. (IF 6.6) Pub Date : 2024-11-08 Maria Chiara De Angelis M.D., Danilo Borrelli M.D., Brunella Zizolfi M.D., Alessandra Gallo M.D., Sardo Attilio Di Spiezio M.D. Ph.D., Jose Carugno M.D.
To describe the technique of embryofetoscopy performed with 5Fr instruments with targeted evacuation of the gestational sac followed by a visual dilatation and curettage (D&C) using the hysteroscopic tissue removal system for the management of first trimester missed abortion in a patient with uterine septum.
-
Childhood adversity and risk of endometriosis, fibroids, and polycystic ovary syndrome: a systematic review Fertil. Steril. (IF 6.6) Pub Date : 2024-11-08 Sara L. Berndt M.Biostat., Leticia Watanabe Ribeiro M.P.H., Ingrid Rowlands Ph.D, Jenny Doust B.M.N.S. Ph.D., Gita D. Mishra Ph.D.
Although childhood adversity has been extensively studied in relation to various health outcomes, investigation of its association with gynecological conditions remains limited.
-
Efficacy and safety of estetrol (15 mg)/drospirenone (3 mg) combination in a cyclic regimen for the treatment of primary and secondary dysmenorrhea: a multicenter, placebo-controlled, double-blind, randomized study Fertil. Steril. (IF 6.6) Pub Date : 2024-11-08 Yutaka Osuga M.D. Ph.D., Takao Kobayashi M.D. Ph.D., Akihiro Hirakawa Ph.D., Toshiaki Takayanagi B.M.L.S., Masayoshi Nogami M.Sc., Kyaw Tayzar M.D. Ph.D., Takayuki Mochiyama M.Pharm., Masashi Hirayama M.Phrama., Jean-Michel Foidart M.D. Ph.D., Tasuku Harada M.D. Ph.D.
To evaluate the efficacy and safety of the estetrol (E4) (15 mg)/drospirenone (DRSP) (3 mg) combination in a cyclic regimen in Japanese women with primary and secondary dysmenorrhea.
-
Early embryo ontogeny and parental genetic legacy: from developmental mechanisms to diagnosis and treatment Fertil. Steril. (IF 6.6) Pub Date : 2024-11-08 Giovanni Coticchio Ph.D., Danilo Cimadomo Ph.D., Antonio Capalbo Ph.D., Laura Rienzi B.Sc. M.Sc.
-
Characteristics and outcomes in endometrioma infections: a cohort of 94 cases Fertil. Steril. (IF 6.6) Pub Date : 2024-11-08 Guillaume Parpex M.D. M.Sc., Martin Belan M.D., Asmaa Tazi M.D. Ph.D., Laetitia Campin M.D., Simon Ganancia M.D., Etienne Canouï M.D., Mathilde Bourdon M.D. Ph.D., Charles Chapron M.D. Ph.D., Louis Marcellin M.D. Ph.D., Caroline Charlier M.D. Ph.D.
-
Preeclampsia: more than just a maternal disease Fertil. Steril. (IF 6.6) Pub Date : 2024-11-08 Robert T. Rydze M.D. M.S.C.I., Stephanie J. Gunderson M.D., Jay Sandlow M.D.
-
Freezing futures: informed decision-making in elective oocyte cryopreservation Fertil. Steril. (IF 6.6) Pub Date : 2024-11-08 Tamar Schiff M.D., Arthur Caplan Ph.D., Gwendolyn P. Quinn Ph.D. F.A.A.C.E.
-
Stepwise approach of hysteroscopic cytoreductive surgery for adenomyosis in patients with recurrent implantation failure Fertil. Steril. (IF 6.6) Pub Date : 2024-11-07 Rudi Campo M.D., Evy Gillet M.D., Stephan Gordts M.D., Marion Valkenburg M.D., Helena Van Kerrebroeck M.D., Alessa Sugihara M.D., Istvan Argay M.D., Panayiotis Tanos M.D.
To study the value of hysteroscopic cytoreductive surgery for adenomyotic lesions to improve reproductive outcomes. We describe a feasible and novel minimal invasive stepwise approach, which did not result in postoperative adhesion formation and restored favorable reproductive outcomes.
-
The effects of BRCA1 and 2 mutations on ovarian reserve and aging Fertil. Steril. (IF 6.6) Pub Date : 2024-11-07 Karine Matevossian D.O., May-Tal Sauerbrun-Cutler M.D., Sanjana Konda A.B., Angela Chen, Alexa Steckler B.A., Joyce Ou M.D. Ph.D., Julia N. McAdams B.S., Ekaterina Snegovskikh, Robin Cram B.A. M.P.A., Jadis T. Chen B.A., Mal Go, Ashley Stuckey M.D., Kathryn J. Grive Ph.D.
-
Pharmacologic and surgical strategies to improve cryopreserved ovarian tissue transplantation longevity and outcomes Fertil. Steril. (IF 6.6) Pub Date : 2024-11-06 Murat Erden M.D., Kutluk H. Oktay M.D. Ph.D.
-
Human embryos with segmental aneuploidies display delayed early development: a multicenter morphokinetic analysis Fertil. Steril. (IF 6.6) Pub Date : 2024-11-05 Matteo Figliuzzi Ph.D., Lorena Bori M.Sc., Christian Simon Ottolini Ph.D., Ludovica Picchetta M.Sc., Silvia Caroselli M.Sc., Marco Reverenna Ph.D., Maurizio Poli Ph.D., Alison Campbell Ph.D., Rachel Smith M.Sc., Giovanni Coticchio Ph.D., Danilo Cimadomo Ph.D., Laura Francesca Rienzi Ph.D., Marcos Meseguer Ph.D., Antonio Capalbo Ph.D.
To assess whether segmental aneuploid embryos display unique morphokinetic patterns.
-
-
Determinants of utilization of infertility services by race and ethnicity in a state with a comprehensive infertility mandate Fertil. Steril. (IF 6.6) Pub Date : 2024-10-31 Ann Korkidakis M.D. M.P.H., Veronica Wang M.S., Riwa Sabbagh M.D., Quetrell Heyward M.D. M.B.A., Michele R. Hacker Sc.D. M.S.P.H., Kim L. Thornton M.D., Alan S. Penzias M.D.
To examine the association between sociodemographic factors and utilization of infertility services by race and ethnicity in a state with a comprehensive infertility mandate.
-
The role of letrozole in in vitro fertilization treatment: new remedy or old mirage? Fertil. Steril. (IF 6.6) Pub Date : 2024-10-31 Nathalie Bülow M.D. Ph.D., Nick Macklon Ph.D.
Aromatase inhibitors, particularly letrozole (LZ), are now established as first-line ovulation induction agents, offering an effective ovarian stimulation strategy to enhance outcomes of intrauterine insemination. In recent years, they have also emerged as potentially valuable adjuvants to gonadotropin ovarian stimulation for in vitro fertilization, particularly in fertility preservation in women with
-
Author reply regarding “Maternal stress in pregnancy and pubertal timing in girls and boys: a cohort study” Fertil. Steril. (IF 6.6) Pub Date : 2024-10-31 Anne Gaml-Sørensen Ph.D., Nis Brix Ph.D., Tine Brink Henriksen Ph.D., Cecilia Høst Ramlau-Hansen Ph.D.
-
Should we rescue clubbed fallopian tubes? A commentary on “Laparoscopic salpingostomy for two types of hydrosalpinx: a step-by-step video tutorial” Fertil. Steril. (IF 6.6) Pub Date : 2024-10-31 Madeline G. Kroeger M.D., Jessica D. Kresowik M.D.
-
Chromosomal abnormalities in oocyte donor candidates: a French survey of over 8200 karyotypes. Fertil. Steril. (IF 6.6) Pub Date : 2024-10-30 Vincent Puy,Badria Bennani Smires,Jean-Pierre Siffroi,Julie Barberet,Marion Bendayan,Oxana Blagosklonov,Florence Brugnon,Rosalie Cabry-Goubet,Marie-Ange Clarotti,Sophie Catteau-Jonard,Céline Chalas,Lucie Chansel-Debordeaux,Béatrice Delepine,Laetitia Hesters,Stéphanie Lattès,Floriane Lefeuve,Arthur Luton,Catherine Metzler-Guillemain,Sophie Mirallié,Joffrey Mons,Valerica-Gabriela Oancea,Nathalie Rives
OBJECTIVE To study karyotypes of more than 8,200 oocyte donor candidates in nulliparous or multiparous women compared to a reference population. DESIGN A retrospective observational multicentric study. SUBJECTS The study included two cohorts of oocyte donor candidates recruited between January 2005 and October 2021: multiparous women with at least one child at the time of recruitment, and nulliparous
-
Exploring new frontiers in the management of polycystic ovary syndrome associated obesity Fertil. Steril. (IF 6.6) Pub Date : 2024-10-28 Anuja Dokras M.D. M.H.C.I. Ph.D., Robert Norman A.O. M.D. C.R.E.I. G.A.I.C.D.